- Home
- SUPN vs MAN Comparison
SUPN vs MAN Comparison
Compare SUPN & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- MAN
- Stock Information
- Founded
- SUPN 2005
- MAN 1948
- Country
- SUPN United States
- MAN United States
- Employees
- SUPN N/A
- MAN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- MAN Professional Services
- Sector
- SUPN Health Care
- MAN Consumer Discretionary
- Exchange
- SUPN Nasdaq
- MAN Nasdaq
- Market Cap
- SUPN 1.9B
- MAN 2.0B
- IPO Year
- SUPN 2012
- MAN 1988
- Fundamental
- Price
- SUPN $33.56
- MAN $42.46
- Analyst Decision
- SUPN Hold
- MAN Hold
- Analyst Count
- SUPN 2
- MAN 5
- Target Price
- SUPN $36.00
- MAN $48.40
- AVG Volume (30 Days)
- SUPN 681.6K
- MAN 1.1M
- Earning Date
- SUPN 08-05-2025
- MAN 07-17-2025
- Dividend Yield
- SUPN N/A
- MAN 5.13%
- EPS Growth
- SUPN N/A
- MAN N/A
- EPS
- SUPN 1.11
- MAN N/A
- Revenue
- SUPN $667,997,000.00
- MAN $17,539,500,000.00
- Revenue This Year
- SUPN N/A
- MAN $0.07
- Revenue Next Year
- SUPN $15.74
- MAN $4.05
- P/E Ratio
- SUPN $30.78
- MAN N/A
- Revenue Growth
- SUPN 11.82
- MAN N/A
- 52 Week Low
- SUPN $27.05
- MAN $37.99
- 52 Week High
- SUPN $40.28
- MAN $77.85
- Technical
- Relative Strength Index (RSI)
- SUPN 57.11
- MAN 46.34
- Support Level
- SUPN $32.94
- MAN $42.11
- Resistance Level
- SUPN $34.21
- MAN $45.91
- Average True Range (ATR)
- SUPN 1.06
- MAN 1.73
- MACD
- SUPN 0.04
- MAN -0.08
- Stochastic Oscillator
- SUPN 56.90
- MAN 9.12
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.